Li et al. discovered that the hepatocellular carcinoma (HCC)-targeted exosome SP94-Lamp2b-RRM facilitates the small interfering RNA delivery to enhance sorafenib-induced ferroptosis by silencing GPX4 and DHODH expression. This evidence concerns the gene GPX4 and hepatocellular carcinoma.